Derma Gran
FDA Label NDC 64772-127

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Derma Sciences Canada, Inc. for the product Derma Gran (NDC 64772-127). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient:, purpose, uses:, warnings, do not use on, otc - stop use, otc - keep out of reach of children, directions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredient:

Zinc Acetate 0.1%

Purpose

Protectant


Uses:

Protects and rehydrates damaged tissue due to rubbing or friction.


Warnings

For external use only.


Do Not Use On

children under 2 years of age without consulting a physician.

Otc - Stop Use

Discontinue use if symptoms persist more than 7 days, and consult a physician.

Avoid contact with eyes.

Otc - Keep Out Of Reach Of Children

Keep this and all medicines out of children's reach.

Directions

  • Apply liberally as often as necessary to abraded skin and irritated areas.
  • Do not wipe, allow to dry.

Other Ingredients:

Alcohol (denatured), Glucose, Methylparaben, Propylparaben, Purified water, Pyridoxine hydrochloride, Sodium chloride, Zinc chloride, Zinc sulfate.


Other

Store at Controlled Room Temperature 15-30 C ( 59-86 F).


Principal Display Panel

DERMA SCiENCES™

NDC 64772-127-52

DERMA GRAN®

MOISTURIZING SPRAY

pH Balanced

Skin Protectant

DM-4

REORDER No.

Net Contents 4 fl oz (118 mL)

Made in Canada

Derma Sciences, Inc., 104 Shorting Road, Toronto

Ontario M1S 3S4 Canada

Questions: In U.S.A. call 1-800-445-7627

In Canada call: 1-800-387-5302

Visit our web site at: www.dermasciences.com

U.S. Patent Number 4,847,083




Untitled.jpg (Untitled)

Untitled.jpg (Untitled)


* Please review the disclaimer below.